Loading chat...
NY A05151
Bill
Status
2/12/2025
Primary Sponsor
Michaelle Solages
Click for details
AI Summary
-
Requires sponsors of clinical trials applying for state grant funding (including pharmaceutical manufacturers, academic medical centers, federal agencies, and health care providers) to post trial information on the Department of Health's website
-
Mandates disclosure of sponsor and funder names, contact information, and institutional affiliations for all parties involved in the trial
-
Requires posting of trial details including the drug name and active ingredients, study design, statistical methods, trial phase, inclusion/exclusion criteria, treatment methods, hypotheses tested, and medical conditions studied
-
Requires health care providers offering clinical trials to post similar information on their own websites, including therapeutic intent, start and end dates, and potential adverse effects
-
Commissioner must promulgate rules for information collection and posting, and monitor compliance with disclosure requirements
Legislative Description
Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.
Last Action
referred to health
1/7/2026